J Aznar

2.4k total citations
81 papers, 1.8k citations indexed

About

J Aznar is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, J Aznar has authored 81 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 28 papers in Pulmonary and Respiratory Medicine and 14 papers in Genetics. Recurrent topics in J Aznar's work include Blood Coagulation and Thrombosis Mechanisms (27 papers), Blood properties and coagulation (21 papers) and Protease and Inhibitor Mechanisms (11 papers). J Aznar is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (27 papers), Blood properties and coagulation (21 papers) and Protease and Inhibitor Mechanisms (11 papers). J Aznar collaborates with scholars based in Spain, United States and Poland. J Aznar's co-authors include A. Estellés, Francisco España, J. Gilabert, Juana Vallés, L B Safier, Guillermo Sáez Tormo, RR Schleef, M. Johan Broekman, H L Ullman and N Islam and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer.

In The Last Decade

J Aznar

79 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Aznar Spain 21 898 418 394 285 255 81 1.8k
Amparo Estellés Spain 31 1.1k 1.2× 352 0.8× 398 1.0× 455 1.6× 473 1.9× 84 2.5k
Giuseppe Cappucci Italy 19 789 0.9× 124 0.3× 459 1.2× 316 1.1× 240 0.9× 27 1.6k
J. Conard France 25 1.8k 2.0× 222 0.5× 913 2.3× 431 1.5× 975 3.8× 94 2.7k
M. Blombäck Sweden 18 552 0.6× 176 0.4× 185 0.5× 90 0.3× 168 0.7× 46 1.0k
Elena M. Faioni Italy 22 1.7k 1.8× 219 0.5× 537 1.4× 98 0.3× 737 2.9× 66 2.3k
Doyeun Oh South Korea 28 389 0.4× 200 0.5× 506 1.3× 98 0.3× 620 2.4× 103 2.2k
KA Bauer United States 21 1.5k 1.6× 461 1.1× 520 1.3× 36 0.1× 613 2.4× 28 2.3k
Eriko Morishita Japan 24 830 0.9× 313 0.7× 385 1.0× 45 0.2× 395 1.5× 166 1.7k
O. Egeberg Norway 20 1.2k 1.4× 311 0.7× 329 0.8× 42 0.1× 434 1.7× 44 1.8k
Patrick Van Dreden France 19 696 0.8× 101 0.2× 324 0.8× 117 0.4× 543 2.1× 101 1.4k

Countries citing papers authored by J Aznar

Since Specialization
Citations

This map shows the geographic impact of J Aznar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Aznar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Aznar more than expected).

Fields of papers citing papers by J Aznar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Aznar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Aznar. The network helps show where J Aznar may publish in the future.

Co-authorship network of co-authors of J Aznar

This figure shows the co-authorship network connecting the top 25 collaborators of J Aznar. A scholar is included among the top collaborators of J Aznar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Aznar. J Aznar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donoso, C.D. Vera, J.F. Jiménez Cruz, Francisco España, et al.. (2001). Factores que influencian el cociente psa:á1antiquimotripsina/psa-total. Actas Urológicas Españolas. 25(5). 350–356. 1 indexed citations
2.
Estellés, A., et al.. (2000). Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familial thrombophilia.. PubMed. 85(1). 111–2. 6 indexed citations
3.
España, Francisco, Paola Villa, Yolanda Mira, et al.. (1999). Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion.. PubMed. 84(1). 80–4. 13 indexed citations
4.
España, Francisco, Manuel Martı́nez, C.D. Vera Donoso, et al.. (1999). RE. The Journal of Urology. 503–503. 9 indexed citations
5.
Martı́nez-Sales, Vicenta, et al.. (1998). Elevated Thrombotic Activity after Myocardial Infarction: A 2-Year Follow-Up Study. Pathophysiology of Haemostasis and Thrombosis. 28(6). 301–306. 24 indexed citations
6.
Vayá, Amparo, et al.. (1998). The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability.. PubMed. 18(4). 259–63. 17 indexed citations
7.
Pastor, A., et al.. (1997). Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. European Respiratory Journal. 10(3). 603–609. 45 indexed citations
8.
9.
10.
Regañón, E., V. Vila, Begoña Laíz, J. Gilabert, & J Aznar. (1993). Decreased High-Molecular Weight Fibrinogen and Impaired Alpha-Chain Polymerization in Full-Term Newborns. Pathophysiology of Haemostasis and Thrombosis. 23(3). 149–158. 7 indexed citations
11.
Vallés, Juana, M. Teresa Santos, J Aznar, et al.. (1991). Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 78(1). 154–162. 181 indexed citations
12.
Vayá, Amparo, et al.. (1989). [Evaluation of erythrocyte deformability in carriers of thalassemic trait with the Hanss' hemorheometer].. PubMed. 34(1). 50–2. 1 indexed citations
13.
Vayá, Amparo, J Aznar, Paola Villa, et al.. (1988). Erythrocyte filterability in patients with cerebrovascular insufficiency. Effect of pentoxifylline and dipyridamole. Preliminary results. Clinical Hemorheology and Microcirculation. 8(5). 773–778. 3 indexed citations
14.
Gilabert, J., José A. Fernández, Francisco España, J Aznar, & A. Estellés. (1988). Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives. Thrombosis Research. 49(3). 319–329. 45 indexed citations
15.
Gilabert, J., et al.. (1987). Congenital Hypofibrinogenemia and Pregnancy, Obstetric and Hematological Management. Gynecologic and Obstetric Investigation. 24(4). 271–276. 9 indexed citations
16.
Aznar, J, A. Estellés, V. Vila, et al.. (1984). Inherited Fibrinolytic Disorder Due to an Enhanced Plasminogen Activator Level. Thrombosis and Haemostasis. 52(2). 196–200. 29 indexed citations
17.
Vila, V., et al.. (1984). Dysfibrinogenaemia associated with a defect in the aggregation of the fibrin monomers (Almeria I fibrinogen). A preliminary study. Scandinavian Journal of Haematology. 33(5). 460–465. 2 indexed citations
18.
Aznar, J, et al.. (1978). Fletcher Factor Deficiency: Report of a New Family. Scandinavian Journal of Haematology. 21(2). 94–98. 16 indexed citations
19.
Aznar, J, Alberto Hernández, Juan José Parrilla, A. Estellés, & J. Gilabert. (1976). Changes in Human Amniotic Fluid Fibrinolytic Inhibitor Levels during Pregnancy. Thrombosis and Haemostasis. 35(2). 382–385. 2 indexed citations
20.
Aznar, J. (1964). [FIBRINOLYTIC PROPERTIES OF THE CONTACT FACTOR].. PubMed. 20. 43–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amparo Estellés Breakdown of academic impact, for papers by Giuseppe Cappucci Breakdown of academic impact, for papers by J. Conard Breakdown of academic impact, for papers by M. Blombäck Breakdown of academic impact, for papers by Elena M. Faioni Breakdown of academic impact, for papers by Doyeun Oh Breakdown of academic impact, for papers by KA Bauer Breakdown of academic impact, for papers by Eriko Morishita Breakdown of academic impact, for papers by O. Egeberg Breakdown of academic impact, for papers by Patrick Van Dreden
Rankless by CCL
2026